Mild cognitive impairment in adult: A neuropsychological review

Ouyang Yanhong1, Mina Chandra, D Venkatesh

  • 1Hainan People's Hospital, First Aid Center EICU, Hainan, China.

Insights

Mild cognitive impairment (MCI) involves memory and executive function deficits, increasing dementia risk. Early diagnosis and treatment of these neuropsychological impairments are crucial for potential dementia prevention.

Area of Science:

  • Neuroscience
  • Gerontology
  • Cognitive Psychology

Background:

  • Mild cognitive impairment (MCI) is a significant risk factor for dementia.
  • Neuropsychological deficits are common in MCI and impact clinical outcomes.
  • Understanding MCI is crucial for developing preventative treatment strategies.

Purpose of the Study:

  • To review neuropsychological deficits in MCI.
  • To present evidence on the nosological status, neuroanatomical basis, and clinical outcomes of MCI.
  • To highlight the heterogeneity of MCI.

Main Methods:

  • Systematic review of published papers on neuropsychological deficits in MCI.
  • Searches conducted on Medline and other databases.
  • Analysis of existing evidence regarding MCI's characteristics and outcomes.

Main Results:

  • Commonly observed deficits in MCI include memory and executive functions.
  • Current evidence for the neuroanatomical basis of MCI is not robust.
  • Inconsistencies in study designs and sample sizes limit current research.
  • Controversies exist regarding the nosological significance of MCI deficits due to varied outcomes.

Conclusions:

  • MCI presents with a range of memory and executive function impairments.
  • Further research is needed to clarify the neuroanatomical underpinnings of MCI.
  • More studies are required to precisely locate impairments and define the MCI construct.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
933
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
696